Literature DB >> 6198600

Cigarette smoke-induced airway oedema due to activation of capsaicin-sensitive vagal afferents and substance P release.

J M Lundberg, C R Martling, A Saria, K Folkers, S Rosell.   

Abstract

Exposure of rats to smoke from one cigarette caused local oedema due to a marked increased in vascular permeability from the epiglottis down to bronchioli, as indicated by extravasation of Evans blue in the airway mucosa. The cigarette smoke-induced extravasation of Evans blue was still present after removal of the tar and nicotine content of the smoke, suggesting that chemical irritants in the vapour phase were the main mediators of the vascular permeability response. Local or systemic pretreatment with capsaicin or [D-Arg1, D-Pro2, D-Trp7,9, Leu11] SP, a substance P antagonist, abolished or significantly reduced the airway oedema induced by cigarette smoke or vagal nerve stimulation. No reduction of the cigarette smoke or vagally induced tracheal oedema was seen upon pretreatment with mepyramine plus cimetidine, fentanyl, disodiumchromoglycate, methylprednisolone or terbutaline. The results thus indicate that the cigarette smoke or vagally induced tracheal oedema is most likely to be due to substance P release from local capsaicin-sensitive afferent neurons in the airway mucosa. Local administration of substance P antagonists may be considered as a pharmacological means of inhibiting local mucosal oedema in the airways caused by airway irritants such as cigarette smoke.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6198600     DOI: 10.1016/0306-4522(83)90117-3

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  32 in total

1.  Substance P contributes to rapidly adapting receptor responses to pulmonary venous congestion in rabbits.

Authors:  A C Bonham; K S Kott; K Ravi; C T Kappagoda; J P Joad
Journal:  J Physiol       Date:  1996-05-15       Impact factor: 5.182

2.  Regulatory peptides in the human soft palate.

Authors:  C Hauser-Kronberger; G W Hacker; W Kummer; K Albegger
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

3.  Effect of inhaled substance P and neurokinin A on the airways of normal and asthmatic subjects.

Authors:  G Joos; R Pauwels; M van der Straeten
Journal:  Thorax       Date:  1987-10       Impact factor: 9.139

4.  Recombinant human enkephalinase (neutral endopeptidase) prevents cough induced by tachykinins in awake guinea pigs.

Authors:  H Kohrogi; J A Nadel; B Malfroy; C Gorman; R Bridenbaugh; J S Patton; D B Borson
Journal:  J Clin Invest       Date:  1989-09       Impact factor: 14.808

5.  A non-peptide NK1-receptor antagonist, RP 67580, inhibits neurogenic inflammation postsynaptically.

Authors:  S M Moussaoui; F Montier; A Carruette; J C Blanchard; P M Laduron; C Garret
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

6.  Effects of two novel tachykinin antagonists, FK224 and FK888, on neurogenic airway plasma exudation, bronchoconstriction and systemic hypotension in guinea-pigs in vivo.

Authors:  Y Hirayama; Y H Lei; P J Barnes; D F Rogers
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

7.  Ruthenium red, but not capsazepine reduces plasma extravasation by cigarette smoke in rat airways.

Authors:  P Geppetti; C Bertrand; J Baker; I Yamawaki; G Piedimonte; J A Nadel
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

8.  Nicotine-induced airway smooth muscle contraction: neural mechanisms involving the airway epithelium. Functional and histologic studies in vitro.

Authors:  H L Hahn; M Lang; S Bleicher; S Zwerenz; C Rausch
Journal:  Clin Investig       Date:  1992 Mar-Apr

9.  Involvement of hydroxyl radicals in neurogenic airway plasma exudation and bronchoconstriction in guinea-pigs in vivo.

Authors:  Y H Lei; P J Barnes; D F Rogers
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

10.  Neurokinin A-induced contraction of guinea-pig isolated trachea: potentiation by hepoxilins.

Authors:  O Laneuville; R Couture; C R Pace-Asciak
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.